Staphylococcus aureus genes and polypeptides

• US 6,403,337 B1
• Filed: 02/24/2000
• Issued: 06/11/2002
• Est. Priority Date: 01/05/1996
• Status: Expired due to Fees

• Current Assignee: Human Genome Sciences Incorporated (GlaxoSmithKline PLC)
• Original Assignee: Human Genome Sciences Incorporated (GlaxoSmithKline PLC)
• Inventors: Choi, Gil H., Bailey, Camella
• Primary Examiner(s): Brusca, John S.
• Application Number:
  US09/512,255
• Time in Patent Office: 838 Days
• Field of Search: 435/69.7, 435/468, 435/252.3, 435/320.1, 536/23.7
• US Class Current: 435/69.7
• CPC Class Codes: A61K 39/00 Medicinal preparations containing antigens or antibodies materials for immunoassay G01N33/53
• CPC Class Codes: C07K 14/31 from Staphylococcus (G)
• CPC Class Codes: C12N 15/1093 General methods of preparing gene libraries, not provided for in other subgroups
• CPC Class Codes: C12N 15/52 Genes encoding for enzymes or proenzymes

Abstract

The present invention relates to novel genes from S. aureus and the polypeptides they encode. Also provided as are vectors, host cells, antibodies and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of S. aureus polypeptide activity. The invention additionally relates to diagnostic methods for detecting Staphylococcus nucleic acids, polypeptides and antibodies in a biological sample. The present invention further relates to novel vaccines for the prevention or attenuation of infection by Staphylococcus.

Claims

1. An isolated nucleic acid molecule comprising a polynucleotide having a nucleotide sequence at least 95% identical to a nucleotide sequence, or the complementary sequence thereto, selected from the group consisting of:

(a) SEQ ID NO;

49, nucleotides 101-655;

(b) SEQ ID NO;

27, nucleotides 106-408;

(c) SEQ ID NO;

25, nucleotides 101-856;

(d) SEQ ID NO;

21, nucleotides 100-1362;

(e) SEQ ID NO;

17, nucleotides 101-958;

(f) SEQ ID NO;

39, nucleotides 101-820;

(g) SEQ ID NO;

3, nucleotides 101-1021;

(h) SEQ ID NO;

23, nucleotides 1883-2101; and

(i) SEQ ID NO;

33, nucleotides 101-1174.

2. An isolated polynucleotide comprising a nucleic acid sequence encoding an amino acid sequence identical to, except for up to five amino acid alterations per 100 amino acids, an amino acid sequence encoded by an ORF selected from the group consisting of:

(a) SEQ ID NO;

49, ORF represented by nucleotides 101-655;

(b) SEQ ID NO;

27, ORF represented by nucleotides 106-408;

(c) SEQ ID NO;

25, ORF represented by nucleotides 101-856;

(d) SEQ ID NO;

21, ORF represented by nucleotides 100-1362;

(e) SEQ ID NO;

17, ORF represented by nucleotides 101-958;

(f) SEQ ID NO;

39, ORF represented by nucleotides 101-820;

(g) SEQ ID NO;

3, ORF represented by nucleotides 101-1021;

(h) SEQ ID NO;

23, ORF fragrnent represented by nucleotides 1883-2101; and

(i) SEQ ID NO;

33, ORF represented by nucleotides 101-1174.

3. The isolated polynucleotide of claim 2, wherein said polynucleotide comprises a heterologous polynucleotide sequence.

4. The isolated polynucleotide of claim 3, wherein said heterologous polynucleotide sequence encodes a heterologous polypeptide.

5. A method for making a recombinant vector comprising inserting the isolated polynucleotide of claim 2 into a vector.

6. A recombinant vector comprising the isolated polynucleotide of claim 2.

7. The recombinant vector of claim 6, wherein said polynucleotide is operably associated with a heterologous regulatory sequence that controls gene expression.

8. A recombinant host cell comprising the isolated polynucleotide of claim 2.

9. The recombinant host cell of claim 8, wherein said polynucleotide is operably associated with a heterologous regulatory sequence that controls gene expression.

10. A method for producing a polypeptide, comprising:

(a) culturing a host cell under conditions suitable to produce a polypeptide encoded by the polynucleotide of claim 2; and

(b) recovering the polypeptide from the cell culture.

11. An isolated polynucleotide comprising a nucleic acid sequence encoding an epitope-bearing portion of an amino acid sequence encoded by an ORF selected from the group consisting of:

(a) SEQ ID NO;

49, ORF represented by nucleotides 101-655;

(b) SEQ ID NO;

27, ORF represented by nucleotides 106-408;

(c) SEQ ID NO;

25, ORF represented by nucleotides 101-856;

(d) SEQ ID NO;

21, ORF represented by nucleotides 100-1362;

(e) SEQ ID NO;

17, ORF represented by nucleotides 101-958;

(f) SEQ ID NO;

39, ORF represented by nucleotides 101-820;

(g) SEQ ID NO;

3, ORF represented by nucleotides 101-1021;

(h) SEQ ID NO;

23, ORF fragment represented by nucleotides 1883-2101; and

(i) SEQ ID NO;

33, ORF represented by nucleotides 101-1174.

12. The isolated polynucleotide of claim 11, wherein said polynucleotide comprises a heterologous polynucleotide sequence.

13. The isolated polynucleotide of claim 12, wherein said heterologous polynucleotide sequence encodes a heterologous polypeptide.

14. A method for making a recombinant vector comprising inserting the isolated polynucleotide of claim 11 into a vector.

15. A recombinant vector comprising the isolated polynucleotide of claim 11.

16. The recombinant vector of claim 15, wherein said polynucleotide is operably associated with a heterologous regulatory sequence that controls gene expression.

17. A recombinant host cell comprising the isolated polynucleotide of claim 11.

18. An isolated polynucleotide comprising a nucleic acid sequence encoding at least 15 contiguous amino acid residues of an amino acid sequence encoded by an ORF selected from the group consisting of:

(a) SEQ ID NO;

49, ORF represented by nucleotides 101-655;

(b) SEQ ID NO;

27, ORF represented by nucleotides 106-408;

(c) SEQ iD NO;

25, ORF represented by nucleotides 101-856;

(d) SEQ ID NO;

21, ORF represented by nucleotides 100-1362;

(e) SEQ ID NO;

17, ORF represented by nucleotides 101-958;

(f) SEQ ID NO;

39, ORF represented by nucleotides 101-820;

(g) SEQ ID NO;

3, ORF represented by nucleotides 101-1021;

(h) SEQ ID NO;

23, ORF fragment represented by nucleotides 1883-2101; and

(i) SEQ ID NO;

33, ORF represented by nucleotides 101-1174.

19. The isolated polynucleotide of claim 18, wherein said polynucleotide comprises a heterologous polynucleotide sequence.

20. The isolated polynucleotide of claim 19, wherein said heterologous polynucleotide sequence encodes a heterologous polypeptide.

21. A method for making a recombinant vector comprising inserting the isolated polynucleotide of claim 18 into a vector.

22. A recombinant vector comprising the isolated polynucleotide of claim 18.

23. The recombinant vector of claim 22, wherein said polynucleotide is operably associated with a heterologous regulatory sequence that controls gene expression.

24. A recombinant host cell comprising the isolated polynucleotide of claim 18.

25. The isolated polynucleotide of claim 18, wherein said polynucleotide comprises a nucleic acid sequence encoding at least 30 contiguous amino acid residues of an amino acid sequence encoded by an ORF selected from the group consisting of:

(a) SEQ ID NO;

49, ORF represented by nucleotides 101-655;

(b) SEQ ID NO;

27, ORF represented by nucleotides 106-408;

(c) SEQ ID NO;

25, ORF represented by nucleotides 101-856;

(d) SEQ ID NO;

21, ORF represented by nucleotides 100-1362;

(e) SEQ ID NO;

17, ORF represented by nucleotides 101-958;

(f) SEQ ID NO;

39, ORF represented by nucleotides 101-820;

(g) SEQ ID NO;

3, ORF represented bynucleotides 101-1021;

(h) SEQ ID NO;

23, ORF fragment represented by nucleotides 1883-2101; and

(i) SEQ ID NO;

33, ORF represented by nucleotides 101-1174.

26. The isolated polynucleotide of claim 25, wherein said polynucleotide comprises a heterologous polynucleotide sequence.

27. The isolated polynucleotide of claim 26, wherein said heterologous polynucleotide sequence encodes a heterologous polypeptide.

28. A method for making a recombinant vector comprising inserting the isolated polynucleotide of claim 25, into a vector.

29. A recombinant vector comprising the isolated polynucleotide of claim 25.

30. The recombinant vector of claim 29, wherein said polynucleotide is operably associated with a heterologous regulatory sequence that controls gene expression.

31. A recombinant host cell comprising the isolated polynucleotide of claim 25.

32. An isolated polynucleotide comprising a nucleic acid sequence which hybridizes under stringent hybridization conditions to an ORF selected from the group consisting of:

(a) SEQ ID NO;

49, ORF represented by nucleotides 101-655;

(b) SEQ ID NO;

27, ORF represented by nucleotides 106-408;

(c) SEQ ID NO;

25, ORF represented by nucleotides 101-856;

(d) SEQ ID NO;

21, ORF represented by nucleotides 100-1362;

(e) SEQ ID NO;

17, ORF represented by nucleotides 101-958;

(f) SEQ ID NO;

39, ORF represented by nucleotides 101-820;

(g) SEQ ID NO;

3, ORF represented by nucleotides 101-1021;

(h) SEQ ID NO;

23, ORF fragment represented by nucleotides 1883-2101; and

(i) SEQ ID NO;

33, ORF represented by nucleotides 101-1174.

33. The isolated polynucleotide of claim 32, wherein said polynucleotide comprises a heterologous polynucleotide sequence.

34. The isolated polynucleotide of claim 33, wherein said heterologous polynucleotide sequence encodes a heterologous polypeptide.

35. A method for making a recombinant vector comprising inserting the isolated polynucleotide of claim 32 into a vector.

36. A recombinant vector comprising the isolated polynucleotide of claim 32.

37. The recombinant vector of claim 36, wherein said polynucleotide is operably associated with a heterologous regulatory sequence that controls gene expression.

38. A recombinant host cell comprising the isolated polynucleotide of claim 32.

48. The isolated polynucleotide of claim 37 comprising at least 100 contiguous nucleotides of an ORF selected from the group consisting of:

(a) SEQ ID NO;

49, ORF represented by nucleotides 101-655;

(b) SEQ ID NO;

27, ORF represented by nucleotides 106-408;

(c) SEQ ID NO;

25, ORF represented by nucleotides 101-856;

(d) SEQ ID NO;

21, ORF represented by nucleotides 100-1362;

(e) SEQ ID NO;

17, ORF represented by nucleotides 101-958;

(f) SEQ ID NO;

39, ORF represented by nucleotides 101-820;

(g) SEQ ID NO;

3, ORF represented by nucleotides 101-1021;

(h) SEQ ID NO;

23, ORF fragment represented by nucleotides 1883-2101; and

(i) SEQ ID NO;

33, ORF represented by nucleotides 101-1174.

49. The isolated polynucleotide of claim 48, wherein said polynucleotide sequence encodes a polypeptide.

50. The isolated polynucleotide of claim 48, wherein said polynucleotide sequence is complementary to a polypeptide encoding polynucleotide sequence.

51. The isolated polynucleotide of claim 48, wherein said polynucleotide comprises a heterologous polynucleotide sequence.

52. The isolated polynucleotide of claim 51, wherein said heterologous polynucleotide sequence encodes a heterologous polypeptide.

53. A method for making a recombinant vector comprising inserting the isolated polynucleotide of claim 48 into a vector.

54. A recombinant vector comprising the isolated polynucleotide of claim 48.

55. The recombinant vector of claim 54, wherein said polynucleotide is operably associated with a heterologous regulatory sequence that controls gene expression.

56. A recombinant host cell comprising the isolated polynucleotide of claim 48.

39. An isolated polynucleotide comprising at least 50 contiguous nucleotides, or the complement thereof, of an ORF selected from the group consisting of:

(a) SEQ ID NO;

49, ORF represented by nucleotides 101-655;

(b) SEQ ID NO;

27, ORF represented by nucleotides 106-408;

(c) SEQ ID NO;

25, ORF represented by nucleotides 101-856;

(d) SEQ ID NO;

21, ORF represented by nucleotides 100-1362;

(e) SEQ ID NO;

17, ORF represented by nucleotides 101-958;

(f) SEQ ID NO;

39, ORF represented by nucleotides 101-820;

(g) SEQ ID NO;

3, ORF represented by nucleotides 101-1021;

(h) SEQ ID NO;

23, ORF fragment represented by nucleotides 1883-2101; and

(i) SEQ ID NO;

33, ORF represented by nucleotides 101-1174.

40. The isolated polynucleotide of claim 39, wherein said polynucleotide sequence encodes a polypeptide.

41. The isolated polynucleotide of claim 39, where in said polynucleotide sequence is complementary to a polypeptide encoding polynucleotide sequence.

42. The isolated polynucleotide of claim 39, wherein said polynucleotide comprises a heterologous polynucleotide sequence.

43. The isolated polynucleotide of claim 42, wherein said heterologous polynucleotide sequence encodes a heterologous polypeptide.

44. A method for making a recombinant vector comprising inserting the isolated polynucleotide of claim 39 into a vector.

45. A recombinant vector comprising the isolated polynucleotide of claim 39.

46. The recombinant vector of claim 45, wherein said polynucleotide is operably associated with a heterologous regulatory sequence that controls gene expression.

47. A recombinant host cell comprising the isolated polynucleotide of claim 39.

57. An isolated nucleic acid molecule comprising a polynucleotide having a nucleotide sequence at least 99% identical to a nucleotides 101-670 of SEQ ID NO:

31, or the complementary sequence thereto.

58. The isolated polynucleotide of claim 57, wherein said polynucleotide comprises a heterologous polynucleotide sequence.

59. The isolated polynucleotide of claim 58, wherein said heterologous polynucleotide sequence encodes a heterologous polypeptide.

60. A method for making a recombinant vector comprising inserting the isolated polynucleotide of claim 57 into a vector.

61. A recombinant vector comprising the isolated polynucleotide of claim 57.

62. The recombinant vector of claim 61, wherein said polynucleotide is operably associated with a heterologous regulatory sequence that controls gene expression.

63. A recombinant host cell comprising the isolated polynucleotide of claim 57.

64. The recombinant host cell of claim 63, wherein said polynucleotide is operably associated with a heterologous regulatory sequence that controls gene expression.

65. A method for producing a polypeptide, comprising:

(a) culturing a host cell under conditions suitable to produce a polypeptide encoded by the polynucleotide of claim 57; and

(b) recovering the polypeptide from the cell culture.